{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:39:53Z","timestamp":1792445993479,"version":"4.5.0"},"reference-count":4,"publisher":"American College of Physicians","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.7326\/annals-26-03576-jc","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:01:04Z","timestamp":1791234064000},"page":"JC113","source":"Crossref","is-referenced-by-count":0,"title":["In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y"],"prefix":"10.7326","volume":"179","author":[{"given":"David S.","family":"Pisetsky","sequence":"first","affiliation":[{"name":"Duke University Medical Center, Durham VAMC, Durham, North Carolina, USA (D.S.P.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4285","reference":[{"key":"ANNALS-26-03576-R1","doi-asserted-by":"crossref","unstructured":"Spiera RF, Unizony S, Warrington KJ, et al; SAPHYR Investigators.\n                      Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper. N Engl J Med. 2023;389:1263-1272. [PMID: 37792612]","DOI":"10.1056\/NEJMoa2303452"},{"key":"ANNALS-26-03576-R2","doi-asserted-by":"crossref","unstructured":"Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, et al.\n                      Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial. JAMA. 2022;328:1053-1062. [PMID: 36125471]","DOI":"10.1001\/jama.2022.15459"},{"key":"ANNALS-26-03576-R3","doi-asserted-by":"crossref","unstructured":"Abacar K, De Marco G, Weddell J, et al.\n                      Late-onset spondyloarthritis presenting as glucocorticoid-resistant polymyalgia rheumatica: a hitherto underappreciated entity in which tumor necrosis factor or interleukin-17 blockade may have a therapeutic role. Arthritis Rheumatol. 2026;78:131-140. [PMID: 40693392]","DOI":"10.1002\/art.43320"},{"key":"ANNALS-26-03576-R4","doi-asserted-by":"crossref","unstructured":"Dejaco C, Matteson EL.\n                      Polymyalgia rheumatica. N Engl J Med. 2026;394:1097-1109. [PMID: 41812194]","DOI":"10.1056\/NEJMcp2506817"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-26-03576-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-26-03576-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:01:52Z","timestamp":1792443712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-26-03576-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.7326\/ANNALS-26-03576-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-26-03576-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}